Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New Oxford start-up is established to develop novel therapeutics based on the expertise of the Davis and Cornall groups at MRC HIU.

Similar stories

Professor Graham Ogg elected Academy of Medical Sciences Fellow

MRC HIU RDM

Fellows are selected for their exceptional contributions to the advancement of medical science through innovative research discoveries and translating scientific developments into benefits for patients and the wider society.

New funding for early diagnosis research using platelets

MRC MHU RDM

Dr Bethan Psaila and her team will investigate the potential of circulating blood platelets for early detection of a range of cancer types.